checkAd

     147  0 Kommentare Marinus Pharmaceuticals Announces Pricing of Public Offering of Common Stock - Seite 3

    Contact
    Sasha Damouni Ellis
    Vice President, Investor Relations & Corporate Communications
    Marinus Pharmaceuticals, Inc.
    484-253-6792
    sdamouni@marinuspharma.com 


    Lesen Sie auch


    globenewswire
    0 Follower
    Autor folgen
    RSS-Feed abonnieren

    Weitere Artikel des Autors

    Seite 3 von 3

    Verfasst von globenewswire
    1 im Artikel enthaltener WertIm Artikel enthaltene Werte
    Marinus Pharmaceuticals Announces Pricing of Public Offering of Common Stock - Seite 3 RADNOR, Pa., May 28, 2020 (GLOBE NEWSWIRE) - Marinus Pharmaceuticals, Inc. (Nasdaq: MRNS) (“Marinus” or the “Company”), a pharmaceutical company dedicated to the development of innovative therapeutics to treat rare seizure disorders, today …